Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system

Journal of Vascular and Interventional Radiology

Volumn 25, Issue 8, 2014, Pages 1233-1239.e2

  Hosein, Peter J ^a   Echenique, Ana ^a   Loaiza Bonilla, Arturo ^a   Froud, Tatiana ^a   Barbery, Katuzka ^a   Rocha Lima, Caio M ^a   Yrizarry, Jose M ^a   Narayanan, Govindarajan ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLUOROPYRIMIDINE; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COLORECTAL LIVER METASTASIS; ELECTROPORATION; FEMALE; GENERAL ANESTHESIA; HUMAN; MALE; OVERALL SURVIVAL; PERCUTANEOUS IRREVERSIBLE ELECTROPORATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; ABLATION THERAPY; ADVERSE EFFECTS; COLORECTAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; ELECTROCHEMOTHERAPY; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RISK FACTOR; SECONDARY; TIME; TREATMENT OUTCOME;

ABLATION TECHNIQUES; AGED; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; ELECTROCHEMOTHERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84905271642     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2014.04.007     Document Type: Article

References (31)

1. G. Steele Jr, and T.S. Ravikumar Resection of hepatic metastases from colorectal cancer. Biologic perspective Ann Surg 210 1989 127 138
2. T.C. Chua, W. Liauw, H.N. Koong, and J. Esquivel Surgical therapies in metastatic colorectal cancer with a potential for cure Am J Clin Oncol 34 2011 326 331
3. J.A. Petrek, and J.P. Minton Treatment of hepatic metastases by percutaneous hepatic arterial infusion Cancer 43 1979 2182 2188
4. F.M. Johnston, M.N. Mavros, J.M. Herman, and T.M. Pawlik Local therapies for hepatic metastases J Natl Compr Canc Netw 11 2013 153 160
5. N.H. Nicolay, D.P. Berry, and R.A. Sharma Liver metastases from colorectal cancer: radioembolization with systemic therapy Nat Rev Clin Oncol 6 2009 687 697
6. S. Krishnan, E.H. Lin, and G.B. Gunn et al. Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases Am J Clin Oncol 29 2006 562 567
7. T. Ruers, C. Punt, and F. Van Coevorden et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004) Ann Oncol 23 2012 2619 2626
8. Y. Komorizono, M. Oketani, and K. Sako et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation Cancer 97 2003 1253 1262
9. D.S. Lu, N.C. Yu, and S.S. Raman et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver Radiology 234 2005 954 960
10. S.K. Kim, H. Rhim, and Y.S. Kim et al. Radiofrequency thermal ablation of hepatic tumors: pitfalls and challenges Abdom Imaging 30 2005 727 733
11. S.W. Kim, H. Rhim, and M. Park et al. Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy Korean J Radiol 10 2009 366 376
12. R.V. Davalos, I.L. Mir, and B. Rubinsky Tissue ablation with irreversible electroporation Ann Biomed Eng 33 2005 223 231
13. M. Faroja, M. Ahmed, and L. Appelbaum et al. Irreversible electroporation ablation: is all the damage nonthermal? Radiology 266 2013 462 470
14. K.R. Thomson, W. Cheung, and S.J. Ellis et al. Investigation of the safety of irreversible electroporation in humans J Vasc Interv Radiol 22 2011 611 621
15. E. Maor, A. Ivorra, J. Leor, and B. Rubinsky The effect of irreversible electroporation on blood vessels Technol Cancer Res Treat 6 2007 307 312
16. R. Cannon, S. Ellis, D. Hayes, G. Narayanan, and R.C. Martin II Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures J Surg Oncol 107 2013 544 549
17. K.P. Charpentier Irreversible electroporation for the ablation of liver tumors: are we there yet? Arch Surg 147 2012 1053 1061
18. T.P. Kingham, A.M. Karkar, and M.I. D'Angelica et al. Ablation of perivascular hepatic malignant tumors with irreversible electroporation J Am Coll Surg 215 2012 379 387
19. G. Narayanan Irreversible electroporation for treatment of liver cancer Gastroenterol Hepatol (NY) 7 2011 313 316
20. G. Narayanan, P.J. Hosein, and G. Arora et al. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma J Vasc Interv Radiol 23 2012 1613 1621
21. M. Pech, A. Janitzky, and J.J. Wendler et al. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study Cardiovasc Intervent Radiol 34 2010 132 138
22. G. Narayanan, T. Froud, R. Suthar, and K. Barbery Irreversible electroporation of hepatic malignancy Semin Intervent Radiol 30 2013 67 73
23. NCI Common Terminology Criteria for Adverse Events (CTCAE) version 4. Bethesda, MD: National Cancer Institute, 2010
24. S.N. Goldberg, C.J. Grassi, and J.F. Cardella et al. Image-guided tumor ablation: standardization of terminology and reporting criteria Radiology 235 2005 728 739
25. E.A. Eisenhauer, P. Therasse, and J. Bogaerts et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
26. R.L. Wahl, H. Jacene, Y. Kasamon, and M.A. Lodge From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors J Nucl Med 50 suppl 1 2009 122S 150S
27. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
28. G. Narayanan, T. Froud, K. Lo, K.J. Barbery, E. Perez-Rojas, and J. Yrizarry Pain analysis in patients with hepatocellular carcinoma: irreversible electroporation versus radiofrequency ablation initial observations Cardiovasc Intervent Radiol 36 2012 176 182
29. K.P. Charpentier, F. Wolf, L. Noble, B. Winn, M. Resnick, and D.E. Dupuy Irreversible electroporation of the liver and liver hilum in swine HPB (Oxford) 13 2011 168 173
30. M. Ahmed, and S.N. Goldberg Thermal ablation therapy for hepatocellular carcinoma J Vasc Interv Radiol 13 suppl 2002 S231 S243
31. M.E. Juweid, S. Stroobants, and O.S. Hoekstra et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma J Clin Oncol 25 2007 571 578